James Peyer - Mar 2, 2022 Form 4/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director, 10%+ Owner
Signature
/s/ Sarah Field, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Mar 2, 2022
Transactions value $
$3,850
Form type
4/A - Amendment
Date filed
6/10/2022, 02:18 PM
Date Of Original Report
Mar 2, 2022
Previous filing
Mar 1, 2022
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $3.85K +1.2K +0.02% $3.20 5.23M Mar 2, 2022 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed solely to correct the number of shares beneficially owned following the transaction reported herein.
F2 These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.